Ikarian Capital »

Ibio shares owned by Ikarian Capital

Quarter-by-quarter ownership of Ibio (IBIO) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Ibio

Tip: Access up to 7 years of quarterly data

All positions including Ibio held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ibio by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.3M 600k 2.11
2024-03-31 $2.4M 600k 4.06

More positions owned by Ikarian Capital

Sarepta Therapeutics Call Option (SRPT)
Amgen Call Option (AMGN)
Bridgebio Pharma Call Option (BBIO)
Immunovant Call Option (IMVT)
Neurocrine Biosciences Call Option (NBIX)
Pyxis Oncology Common Stock Call Option (PYXS)
Insmed Com Par $.01 Call Option (INSM)
Abeona Therapeutics Com New Call Option (ABEO)
Alnylam Pharmaceuticals Put Option (ALNY)
Aerovate Therapeutics Call Option (AVTE)
Rapt Therapeutics Call Option (RAPT)
Praxis Precision Medicines I Com New Call Option (PRAX)
Crinetics Pharmaceuticals In (CRNX)
Tarsus Pharmaceuticals (TARS)
Soleno Therapeutics (SLNO)

View all positions for Ikarian Capital

Top funds holding Ibio

Ikarian Capital
Lynx1 Capital Management
Opaleye Management
Geode Capital Management
Vanguard Group
Dimensional Fund Advisors
BlackRock
Tower Research Capital
IFP Advisors
Group One Trading
Bank of America Corporation
Morgan Stanley
Citigroup
Harbour Investments
Royal Bank of Canada

View all funds holding Ibio